TENX — Tenax Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- $256.24m
- $158.68m
Annual balance sheet for Tenax Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 5.58 | 2.12 | 9.79 | 94.9 | 97.6 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5.69 | 3.21 | 11.7 | 96.7 | 104 |
| Net Property, Plant And Equipment | 0.295 | 0.187 | 0 | — | — |
| Other Long Term Assets | |||||
| Total Assets | 5.99 | 3.4 | 11.7 | 96.7 | 104 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Current Liabilities | 1.56 | 1.85 | 3.59 | 4.69 | 7.16 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.75 | 1.91 | 3.59 | 4.69 | 7.16 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 4.24 | 1.49 | 8.1 | 92 | 97.1 |
| Total Liabilities & Shareholders' Equity | 5.99 | 3.4 | 11.7 | 96.7 | 104 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |